Smoldering type adult T‐cell leukemia/lymphoma effectively treated with mogamulizumab (anti‐CC chemokine receptor 4 monoclonal antibody)—A case report

The use of mogamulizumab needs careful consideration because of severe adverse reactions such as graft‐vs‐host disease. However, refractory specific skin lesions of smoldering type adult T‐cell leukemia/lymphoma can be effectively treated with mogamulizumab when patients have no opportunity to recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Yotaro, Mochida, Kosuke, Kubo, Tamaki, Horikawa, Nagako, Nemoto, Rieko, Amano, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509667/
https://www.ncbi.nlm.nih.gov/pubmed/31110745
http://dx.doi.org/10.1002/ccr3.2155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509667/
https://www.ncbi.nlm.nih.gov/pubmed/31110745
http://dx.doi.org/10.1002/ccr3.2155

Ejemplares similares